Patent Yard Sign in
Expired Canadian patentCanada

Esters of 1,4-ethano-10-hydroxy-5-oxo-5h-1 benzopyrano 3,4-b pyridine

CA 1095519 A · Owner: Abbott Laboratories · Inventors: Arendsen, David L.; Zaugg, Harold E.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed are compounds of the formula useful in reducing the intra-ocular pressure in mammalian patients wherein R is a straight or branched chain alkanoyl group having from 2-8 carbon atoms or with Y being a straight or branched chain alkylene group having from 1-8 carbon atoms; a is an integer from 1-4; b is an integer from 1-4; X is CH2, O, S or NR1 with R1, being hydrogen or lower alkyl with the limitation that when X is O, S, or NR1, the sum of a and b is 3 or 4 and, pharmaceutically acceptable acid addition salts thereof.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted February 10, 1981. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 10, 1998.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 16, 1978
GrantedFebruary 10, 1981
Term endedFebruary 10, 1998
Patent numberCA 1095519 A
Classification (IPC)C07D491/18

Timeline

Timeline From CIPO dates

1979198119831985198719891991199319951997Application filedFeb 16, 1978Patent grantedFeb 10, 1981Term endedFeb 10, 1998

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.